ISSN: 1885-5857 Impact factor 2023 7.2
Vol. 62. Num. 3.
Pages 323-327 (March 2009)

Effect of Statin Treatment on Mortality in a Large Cohort of Heart Failure Patients

Efecto del tratamiento con estatinas en la mortalidad de una gran cohorte de pacientes con insuficiencia cardiaca

Alejandro J JordánaManuel P Anguitab

Options

We studied 3162 heart failure patients included in the Spanish BADAPIC registry in order to determine whether statin treatment influences prognosis. Patients were followed up for 35±22 months (median, 32 months). Patients on statins were more often male and had higher prevalences of risk factors, ischemic heart disease and systolic dysfunction (P<.001) than those not on statins. After adjustment for age, risk factors, ischemic heart disease, renal failure, ejection fraction, anemia, heart rate and drug treatment, statin treatment was found to be a favorable independent predictor of survival: the hazard ratio for mortality was 0.73 (95% confidence interval, 0.45¿0.88; P<.001). During follow-up, the 3-year survival rate was higher in patients treated with statins (75% vs. 68%; P<.001). In patients with heart failure, statin treatment appears to be independently associated with better survival.

Keywords

Heart failure
Statins
Prognosis
Este artículo solo puede leerse en pdf
Bibliography
[1]
Levine B, Kalman J, Mayer L, Fillit HM, Packer M..
Elevated circulating levels of tumor necrosis factor in congestive heart failure..
N Engl J Med, (1990), 323 pp. 236-41
[2]
Kotlyar E, Vita JA, Winter MR, Awtry EH, Siwik DA, Keaney JF Jr, et al..
The relationship between aldosterone, oxidative stress and inflammation in chronic, stable human heart failure..
J Card Fail, (2006), 12 pp. 122-7
[3]
Sola S, Mir MQ, Lerakis S, Tandon N, Khan BV..
Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure..
J Am Coll Cardiol, (2006), 47 pp. 332-7
[4]
Anguita M y el grupo de investigadores del registro BADAPIC..
Características clínicas, tratamiento y morbimortalidad a corto plazo de pacientes con insuficiencia cardíaca controlados en consultas específicas de insuficiencia cardíaca. Resultados del Registro BADAPIC..
Rev Esp Cardiol, (2004), 57 pp. 1159-69
[5]
Guías para el diagnóstico y manejo de la insuficiencia cardíaca y shock cardiogénico. Informe del Grupo de Trabajo de Insuficiencia Cardíaca de la Sociedad Española de Cardiología. Rev Esp Cardiol. 1999;52 Supl 2:1-54.
[6]
Guidelines for the diagnosis and treatment of chronic heart failure..
The Task Force for the diagnosis and treatment of chronic heart failure. European Society of Cardiology..
Eur Heart J, (2001), 22 pp. 1527-60
[7]
Statistics in epidemiology. Methods, techniques and applications. CRC Press; 1996.
[8]
Ulm M..
A simple method to calculate the confidence interval of a standarized mortality ratio..
Am J Epidemiol, (1990), 131 pp. 373-5
[9]
Horwich TB, MacLellan WR, Fonarow GC..
Statin therapy is associated with improved survival in ischemic and nonischemic heart failure..
J Am Coll Cardiol, (2004), 43 pp. 642-8
[10]
Mozaffarian D, Nye R, Levy WC..
Statin therapy is associated with lower mortality among patients with severe heart failure..
Am J Cardiol, (2004), 93 pp. 1124-9
[11]
Ray JG, Gong Y, Sykora K, Tu JV..
Statin use and survival outcomes in elderly patients with heart failure..
Arch Intern Med, (2005), 165 pp. 62-7
[12]
Foody JM, Shah R, Galusha D, Masoudi FA, Havranek EP, Krumholz HM..
Statins and mortality among elderly patients hospitalized with heart failure..
Circulation, (2006), 113 pp. 1086-92
[13]
Kjekshus J, Apetrel E, Barrios V, Böhm M, Cleland J, Cornel J, et al..
Rosuvastatin in older patients with systolic heart failure..
N Engl J Med, (2007), 357 pp. 2248-61
[14]
Tavazzi L, Tognoni G, Franzosi MG, Latini R, Maggioni AP, Marchioli R, et al..
Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure..
Eur J Heart Fail, (2004), 6 pp. 635-41
Are you a healthcare professional authorized to prescribe or dispense medications?